PharmaShots | Incisive News in 3 Shots

Subscribe Now

AdvancedBasal Cell Carcinoma

Regeneron and Sanofi's Libtayo (cemiplimab) Receive the EC's Approval as 1L Treatment for Advanced Basal Cell Carcinoma

Regeneron and Sanofi's Libtayo (cemiplimab) Receive the EC's Approval as 1L Treatment for Advanced Basal Cell Carcinoma

June 25, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us